drugset / Trial / NCT01355133

Safety and Efficacy Study of Intrasphincteric Autologous Myoblast Injection to Treat Stress Urinary Incontinence

NCT01355133 ↗

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this pilot clinical study is to determine if intrasphincteric autologous myoblast injections in combination with electrical stimulation are safe and effective in treating stress urinary incontinence, confirming the optimal dose and assessing tolerability of the procedure.

Timeline

Start
2009-08
Primary completion
2011-02
Completion
2011-02

Drugs

EvaluationDrugModalityDoseRoute
Subject autologous myoblasts Cell therapy 1e+06 cells Other
Subject autologous myoblasts Cell therapy 5e+07 cells Other